These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 20454876)

  • 1. Influence of formulation and processing factors on stability of levothyroxine sodium pentahydrate.
    Collier JW; Shah RB; Gupta A; Sayeed V; Habib MJ; Khan MA
    AAPS PharmSciTech; 2010 Jun; 11(2):818-25. PubMed ID: 20454876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the Influence of Excipients on the Stability of Levothyroxine Sodium Pentahydrate.
    Kaur N; Suryanarayanan R
    Mol Pharm; 2021 Jul; 18(7):2683-2693. PubMed ID: 34061524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of excipients on the stability of levothyroxine sodium pentahydrate tablets.
    Patel H; Stalcup A; Dansereau R; Sakr A
    Int J Pharm; 2003 Oct; 264(1-2):35-43. PubMed ID: 12972334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levothyroxine Sodium Pentahydrate Tablets - Formulation Considerations.
    Kaur N; Suryanarayanan R
    J Pharm Sci; 2021 Dec; 110(12):3743-3756. PubMed ID: 34384799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial Dehydration of Levothyroxine Sodium Pentahydrate in a Drug Product Environment: Structural Insights into Stability.
    Kaur N; Young VG; Su Y; Suryanarayanan R
    Mol Pharm; 2020 Oct; 17(10):3915-3929. PubMed ID: 32960611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutual Impact of Phase Separation/Crystallization and Water Sorption in Amorphous Solid Dispersions.
    Luebbert C; Wessner M; Sadowski G
    Mol Pharm; 2018 Feb; 15(2):669-678. PubMed ID: 29309155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Physical Stability of PVP- and PVPVA-Amorphous Solid Dispersions.
    Lehmkemper K; Kyeremateng SO; Heinzerling O; Degenhardt M; Sadowski G
    Mol Pharm; 2017 Jan; 14(1):157-171. PubMed ID: 28043133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?
    Veith H; Wiechert F; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2021 Jan; 158():323-335. PubMed ID: 33296719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative Humidity Cycling: Implications on the Stability of Moisture-Sensitive Drugs in Solid Pharmaceutical Products.
    Veronica N; Heng PWS; Liew CV
    Mol Pharm; 2023 Feb; 20(2):1072-1085. PubMed ID: 36480246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Polymer Type and Relative Humidity on the Long-Term Physical Stability of Amorphous Solid Dispersions.
    Lehmkemper K; Kyeremateng SO; Heinzerling O; Degenhardt M; Sadowski G
    Mol Pharm; 2017 Dec; 14(12):4374-4386. PubMed ID: 29050468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The solution and solid state stability and excipient compatibility of parthenolide in feverfew.
    Jin P; Madieh S; Augsburger LL
    AAPS PharmSciTech; 2007 Dec; 8(4):E105. PubMed ID: 18181526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of physicochemical factors affecting the stability of a pH-modulated solid dispersion and a tablet during storage.
    Tran PH; Tran TT; Park JB; Min DH; Choi HG; Han HK; Rhee YS; Lee BJ
    Int J Pharm; 2011 Jul; 414(1-2):48-55. PubMed ID: 21565260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stability of benzocaine formulated in commercial oral disintegrating tablet platforms.
    Köllmer M; Popescu C; Manda P; Zhou L; Gemeinhart RA
    AAPS PharmSciTech; 2013 Dec; 14(4):1333-40. PubMed ID: 23990120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of an extemporaneously compounded levothyroxine sodium oral liquid.
    Boulton DW; Fawcett JP; Woods DJ
    Am J Health Syst Pharm; 1996 May; 53(10):1157-61. PubMed ID: 8734676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding the Roles of Excipients in Moisture Management in Solid Dosage Forms.
    Veronica N; Heng PWS; Liew CV
    Mol Pharm; 2024 May; 21(5):2484-2500. PubMed ID: 38647432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Influence of Tablet Formulation, Drug Concentration, and pH Modification on the Stability of Extemporaneously Compounded Levothyroxine Suspensions.
    Svirskis D; Lin SW; Brown H; Sangaroomthong A; Shin D; Wang Z; Xu H; Dean R; Vareed P; Jensen M; Wu Z
    Int J Pharm Compd; 2018; 22(2):164-171. PubMed ID: 29877863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moisture sorption by polymeric excipients commonly used in amorphous solid dispersion and its effect on glass transition temperature: I. Polyvinylpyrrolidone and related copolymers.
    Patel NG; Serajuddin ATM
    Int J Pharm; 2022 Mar; 616():121532. PubMed ID: 35121046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of water in the physical stability of solid dosage formulations.
    Airaksinen S; Karjalainen M; Shevchenko A; Westermarck S; Leppänen E; Rantanen J; Yliruusi J
    J Pharm Sci; 2005 Oct; 94(10):2147-65. PubMed ID: 16136577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Miniaturized approach for excipient selection during the development of oral solid dosage form.
    Raijada D; Müllertz A; Cornett C; Munk T; Sonnergaard J; Rantanen J
    J Pharm Sci; 2014 Mar; 103(3):900-8. PubMed ID: 24436033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of drug-excipient interaction in the formulation of celecoxib tablets.
    Bozdağ-Pehlivan S; Subaşi B; Vural I; Unlü N; Capan Y
    Acta Pol Pharm; 2011; 68(3):423-33. PubMed ID: 21648198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.